These compounds may interact with:
Metabotropic glutamate receptor 2
Potentially involved in: carcinoma; schizophrenia; cocaine dependence; epilepsy; major depressive disorder; parkinson's disease; toxic encephalopathy; alcoholic intoxication, chronic; epilepsy, temporal lobe; psychoses, substance-induced; amphetamine-related disorders; mood disorders; addicted to cocaine; astrocytoma, pilocytic; atypical teratoid / rhabdoid tumor; ependymoma; glioblastoma; pediatric high grade glioma; primitive neuroectodermal tumor
Disease data sourced from Pharos.